Sort
25,944 grants matching “neurodegeneration”
IDENTIFICATION OF THE MOLECULAR BASIS OF PROTEOTOXICITY PROTECTION
$384,546Jeffery W Kelly · Scripps Research Institute, The · P01 · FY2009 · AG
Molecular mechanisms of lung disease in ataxia telangiectasia
$384,546Joann M Sekiguchi · University Of Michigan At Ann Arbor · R01 · FY2011 · HL
Conditional Control of Drug Function Through α-Boryl Ether Oxidation
$384,484Paul E Floreancig · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · GM
Conditional Control of Drug Function Through α-Boryl Ether Oxidation
$384,484Paul E Floreancig · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · GM
Conditional Control of Drug Function Through α-Boryl Ether Oxidation
$384,484Paul E Floreancig · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · GM
Conditional Control of Drug Function Through α-Boryl Ether Oxidation
$384,484Paul E Floreancig · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · GM
Novel Story Recall Measures as Indicators of Cognitive Decline Associated with Alzheimer's Disease and Related Disorders Biomarkers: A Collaborative Study of Existing Data
$384,437Kimberly D Mueller · University Of Wisconsin-Madison · R01 · FY2023 · AG
Novel Story Recall Measures as Indicators of Cognitive Decline Associated with Alzheimer's Disease and Related Disorders Biomarkers: A Collaborative Study of Existing Data
$384,437Kimberly D Mueller · University Of Wisconsin-Madison · R01 · FY2024 · AG
Two-Photon Microscopy of Oxygen Consumption in the Brain
$384,403Sava Sakadzic · Massachusetts General Hospital · R01 · FY2015 · NS
Heterogeneity of synaptic NMDA Receptors
$384,399Stefano Vicini · Georgetown University · R01 · FY2011 · NS
Role of sumoylation during stress signaling responses
$384,385Richard George Gardner · University Of Washington · R35 · FY2021 · GM
Role of sumoylation during stress signaling responses
$384,385Yasemin S Sancak · University Of Washington · R35 · FY2022 · GM
Treatment of Catecholaminergic Neurodegeneration
$384,365David Goldstein · National Institute Of Neurological Disorders And Stroke · ZIA · FY2018 · NS
Attenuating ER and oxidative stress signaling to reduce cell degeneration in vivo
$384,363Feroz R Papa · University Of California, San Francisco · R01 · FY2016 · DK
Attenuating ER and oxidative stress signaling to reduce cell degeneration in vivo
$384,363Feroz R Papa · University Of California, San Francisco · R01 · FY2015 · DK
THE ROLE OF ZFYVE21 IN CEREBRAL AMYLOID ANGIOPATHY IN ALZHEIMER'S DISEASE
$384,362Daniel Jane-Wit · Yale University · R01 · FY2021 · HL
Resilience and Resistance Phenotypes
$384,337Susan Y Bookheimer · Boston University Medical Campus · U19 · FY2022 · AG
Engineered multi-therapeutic agents delivery system towards retinal ganglion cell axon regeneration
$384,310Dae Won Park · University Of Colorado Denver · R01 · FY2020 · EY
Engineered multi-therapeutic agents delivery system towards retinal ganglion cell axon regeneration
$384,310Dae Won Park · University Of Colorado Denver · R01 · FY2023 · EY
Hippocampal Cellular Rhythms
$384,302Karl H Obrietan · Ohio State University · R01 · FY2014 · MH
Hippocampal Cellular Rhythms
$384,302Karl H Obrietan · Ohio State University · R01 · FY2015 · MH
Role of Parkin in Familial and Idiopathic Parkinson's Disease
$384,257Matthew J Lavoie · Brigham And Women'S Hospital · R01 · FY2010 · NS
Studies of SLC41A1, a Mg2+-Transporting Protein Linked to Parkinson's Disease
$384,200Lejla Zubcevic · University Of Kansas Medical Center · R01 · FY2023 · NS
Signaling Scaffolds for Specificity in Neuromodulator Action
$384,198Oliver Schlueter · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · NS
Anesthesia-Induced Developmental Neuroapoptosis in non-Human Primates
$384,185John W Olney · Washington University · R01 · FY2010 · HD